AU Stock MarketDetailed Quotes

NEU Neuren Pharmaceuticals Ltd

Watchlist
  • 15.520
  • +0.310+2.04%
20min DelayNot Open Aug 23 16:00 AET
2.02BMarket Cap12.92P/E (Static)

Neuren Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neuren Pharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 111.000M--
--2024/H1-- / 24.100M--
Feb 29, 20242023/H2168.999M / 169.600M--
Aug 28, 20232023/H164.405M / 63.100M--
--2022/H216.750M / 13.900M--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 111.000M--
--2024/H1-- / 24.100M--
Feb 29, 20242023/H2168.999M / 169.600M--
Aug 28, 20232023/H164.405M / 63.100M--
--2022/H216.750M / 13.900M--

Unlock Free Earnings Estimates

Neuren Pharmaceuticals Ltd Earnings Reports

  • Neuren Pharmaceuticals Ltd: 2023 Annual Report to shareholders

    Apr 22 19:16 ET

  • Neuren Pharmaceuticals Ltd: 2023 Results webinar

    Feb 29 00:17 ET

  • Neuren Pharmaceuticals Ltd: Neuren reports profit of $157 million for 2023

    Feb 28 23:40 ET

  • Neuren Pharmaceuticals Ltd: Appendix 4E and 2023 full year accounts

    Feb 28 23:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 13, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    AU
    Overall
    Symbol
    Latest Price
    % Chg